This article provides a comprehensive overview of the latest advancements in biomaterial scaffolds for stem cell delivery, a cornerstone of regenerative medicine.
This article provides a comprehensive analysis of oncogenic risk assessment across diverse stem cell types, including pluripotent stem cells (PSCs), induced pluripotent stem cells (iPSCs), and adult stem cells.
This article provides a comprehensive comparative analysis of evolving global regulatory frameworks, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive safety profile assessment of stem cell-based therapies for researchers, scientists, and drug development professionals.
This article provides a systematic comparison of two-dimensional (2D) and three-dimensional (3D) cell culture systems, analyzing their efficacy in mimicking in vivo conditions for biomedical research and drug development.
This comprehensive review addresses the critical challenge of tumorigenicity in stem cell-based therapies, a paramount concern for researchers and drug development professionals.
This article provides a comprehensive analysis of comparative biodistribution assessment for cell therapy products (CTPs), a critical component for evaluating their safety and efficacy.
This article provides a comprehensive analysis of the biological signatures of freshly cultured versus cryopreserved Mesenchymal Stem Cells (MSCs), a central debate in regenerative medicine.
This article provides a comprehensive framework for standardizing cell viability assessment across multiple cell culture passages, a critical yet often overlooked variable in biomedical research.
This article provides a comprehensive analysis of strategies to overcome the central challenge of tumorigenicity in pluripotent stem cell (PSC)-derived therapies.